![]() |
市场调查报告书
商品编码
1930020
肢体义肢市场规模、占有率、成长及全球产业分析:按类型、应用和地区划分的洞察与预测(2026-2034)Limb Prosthetics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
由于慢性疾病、创伤和血管疾病导致的截肢病例不断增加,全球肢体义肢市场正经历稳定成长。根据 Fortune Business Insights 预测,全球义肢市场规模预计在 2025 年达到 18.5 亿美元,并在 2026 年达到 19.5 亿美元。长期来看,该市场预计将进一步扩张,到 2034 年达到 30.9 亿美元,2026 年至 2034 年的复合年增长率 (CAGR) 为 5.89%。
北美将在 2025 年占义肢市场的主导地位,市占率将达到 50.05%,这主要得益于美国和加拿大较高的肢体缺失率、先进义肢技术的早期应用、有利的报销制度以及强劲的医疗保健支出。
市场概览
义肢是用来取代缺失肢体、矫正身体畸形和恢復功能性活动能力的医疗器材。糖尿病、週边血管疾病、癌症、感染和创伤的日益普遍导致全球截肢数量显着增加,从而推动了对义肢解决方案的需求。在新冠疫情期间,由于患者就诊量减少和手术延迟,市场出现萎缩,但自2021年以来,随着常规医疗服务的恢復,市场呈现復苏趋势。
正在进行的旨在开发先进义肢设计的临床试验和功能评估研究进一步增强了市场前景。持续的技术创新仍然是製造商和研究机构关注的重点领域。
新冠疫情的影响
2020年,新冠疫情对肢体义肢市场造成了负面影响,主要原因是医师预约取消和择期手术减少。在此期间,主要公司的收入均有所下降。然而,随着限制措施的放鬆和患者就诊量的增加,市场在2021年和2022年出现了復苏迹象。远距医疗和数位技术的应用使多家义肢服务提供者得以继续运营,从而促进了市场的稳定和逐步成长。
市场趋势
影响市场发展的关键趋势之一是肌电和脑电图 (EEG) 控制义肢的研发。这些先进的设备能够实现更自然的肢体运动,并改善患者的治疗效果。製造商正日益关注机器人技术、神经介面和微处理器控制系统,以增强义肢的功能和使用者舒适度。预计这些技术进步将在预测期内推动义肢的普及。
成长因素
截肢数增加
创伤和慢性疾病导致的截肢数量不断增加,仍然是市场成长的主要驱动因素。週边血管疾病和糖尿病会显着增加截肢的风险,尤其是在老年族群。涵盖咨询、安装和设备更换的优惠报销政策进一步促进了已开发地区肢体义肢的普及。
技术进步
动力膝关节、轻质材料和防水微处理器控制关节等先进技术的应用,正在改善截肢患者的行动能力和长期健康状况。製造商正大力投资研发,推出满足患者对舒适性、耐用性和功能性期望的创新产品。
限制因子
儘管需求强劲,但设备成本高昂仍是一项主要挑战。先进的仿生和肌电义肢价格昂贵,限制了其普及程度,尤其是在报销体系薄弱的新兴经济体。此外,部分地区训练有素的义肢技师短缺也阻碍了市场扩张和普及。
按类型
此市场细分为上肢义肢和下肢义肢。
受下肢截肢率高且产品持续创新的推动,下肢义肢预计在2026年将占市场占有率的62.11%。预计上肢义肢的成长速度相对较慢。
依科技
依技术划分,义肢分为传统型、动力型和混合型。
由于价格实惠且普及性强,传统型义肢预计在2026年将占市场占有率的45.10%。动力型义肢因其功能改进和有利的报销政策而备受关注。
依最终使用者划分
按最终用户划分,市场可分为矫形器和义肢 (O&P) 诊所、骨科诊所和其他机构。
到 2026 年,O&P 诊所将占市场主导地位,市占率高达 87.37%,这主要得益于其专业服务、客製化能力和报销优势。
北美仍将是领先地区,到 2025 年市场规模将达到 9.3 亿美元。
欧洲将占第二大市场占有率,这主要得益于其有利的报销政策和积极的研发活动。
由于人口老化和糖尿病患者人数不断增加,预计亚太地区将实现最快成长。
The global limb prosthetics market is experiencing steady growth due to the rising incidence of amputations caused by chronic diseases, trauma, and vascular disorders. According to Fortune Business Insights, the global limb prosthetics market was valued at USD 1.85 billion in 2025 and is projected to reach USD 1.95 billion in 2026. Over the long term, the market is expected to expand further and attain a value of USD 3.09 billion by 2034, registering a compound annual growth rate (CAGR) of 5.89% during the forecast period from 2026 to 2034.
North America dominated the limb prosthetics market with a 50.05% share in 2025, supported by a high prevalence of limb loss, early adoption of advanced prosthetic technologies, favorable reimbursement frameworks, and strong healthcare expenditure in the U.S. and Canada.
Market Overview
Limb prosthetics are medical devices prescribed to replace missing limbs, correct physical deformities, and restore functional mobility. The increasing prevalence of diabetes, peripheral vascular disease, cancer, infections, and traumatic injuries has significantly increased the global volume of amputations, thereby driving demand for prosthetic solutions. Although the market experienced a decline during the COVID-19 pandemic due to reduced patient visits and postponed procedures, recovery was observed from 2021 onward with the resumption of routine healthcare services.
Ongoing clinical trials and functional assessment studies aimed at developing advanced prosthetic designs are further strengthening the market outlook. Continuous innovation remains a key focus area for manufacturers and research institutions.
COVID-19 Impact
The COVID-19 pandemic negatively affected the limb prosthetics market in 2020, primarily due to appointment cancellations and reduced elective procedures. Major companies reported revenue declines during this period. However, recovery was observed in 2021 and 2022 as restrictions were lifted and patient visits increased. Adoption of teleconsultation and digital technologies enabled several prosthetic service providers to sustain operations, contributing to market stabilization and gradual growth.
Market Trends
One of the key trends shaping the market is the development of myoelectric and mind-controlled prostheses. These advanced devices enable more natural limb movement and improved patient outcomes. Manufacturers are increasingly focusing on robotics, neural interfaces, and microprocessor-controlled systems to enhance prosthetic functionality and user comfort. Such technological advancements are expected to increase adoption rates during the forecast period.
Growth Drivers
Rising Number of Amputations
The growing incidence of amputations due to traumatic injuries and chronic conditions remains the primary driver of market growth. Peripheral vascular disease and diabetes significantly increase the risk of limb loss, especially among elderly populations. Favorable reimbursement policies covering consultations, fittings, and device replacements further support the adoption of limb prosthetics in developed regions.
Technological Advancements
The incorporation of cutting-edge technologies, such as powered knees, lightweight materials, and waterproof microprocessor-controlled joints, is improving mobility and long-term health outcomes for amputees. Manufacturers are investing heavily in R&D to introduce innovative products that meet patient expectations for comfort, durability, and functionality.
Restraining Factors
Despite strong demand, high device costs remain a major challenge. Advanced bionic and myoelectric prostheses can be expensive, limiting affordability, particularly in emerging economies with weak reimbursement frameworks. Additionally, the shortage of trained prosthetists and orthotists in several regions restricts market expansion and accessibility.
By Type
The market is segmented into upper limb and lower limb prosthetics.
Lower limb prosthetics accounted for 62.11% of the market in 2026, driven by the high incidence of lower limb amputations and continuous product innovations. Upper limb prosthetics are expected to grow at a comparatively moderate pace.
By Technology
Based on technology, the market includes conventional, electric, and hybrid prosthetic devices.
Conventional prosthetic devices held a 45.10% share in 2026, owing to affordability and widespread availability. Electric prosthetics are gaining traction due to improved functionality and favorable reimbursement support.
By End User
By end user, the market is segmented into Orthotists & Prosthetists (O&P) clinics, orthopedic clinics, and others.
O&P clinics dominated the market with an 87.37% share in 2026, supported by specialized services, customization capabilities, and reimbursement advantages.
North America remains the leading region, with a market value of USD 0.93 billion in 2025.
Europe holds the second-largest share, driven by favorable reimbursement policies and strong R&D activity.
Asia Pacific is expected to grow at the fastest rate due to a rising elderly population and increasing prevalence of diabetes.
Competitive Landscape
Key players such as Ottobock and Ossur hold strong market positions due to diversified product portfolios, geographic reach, and continuous innovation. Other companies, including Blatchford, Steeper Inc., Hanger Inc., and Fillauer LLC, are expanding their presence through product launches, collaborations, and manufacturing expansion.
Conclusion
In conclusion, the global limb prosthetics market, valued at USD 1.85 billion in 2025, is projected to grow to USD 1.95 billion in 2026 and further reach USD 3.09 billion by 2034. Rising amputation rates, technological advancements, and favorable reimbursement policies will continue to support steady market growth during the forecast period.
Segmentation By Type, Technology, Component, End User, and Region
By Type * Upper Limb Prosthetics
By Technology * Conventional Prosthetic Devices
By Component * Socket
By End-user
Orthotists & Prosthetists (O&P) Clinics
By Region * North America (By Type, By Technology, By Component, By End User, and By Country)